Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
ConditionColorectal Carcinoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45+
SponsorMayo Clinic
About this trial
This clinical trial studies disparities involving colorectal cancer prevention and screening in Black and underserved communities in the Phoenix metropolitan area. The Black community is disproportionately impacted by colorectal cancer, with the highest rate of any racial/ethnic group in the United States. There are complex reasons behind these disparities, largely related to socioeconomic factors and healthcare access. Providing access to free, home-based fecal immunochemical testing (FIT), colorectal screening education, and appropriate follow-up to predominantly Black community-based organizations and underserved communities may help to close this gap.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age 45 years of age or older
No prior history of colorectal cancer or colon polyps
No first-degree family history of colorectal cancer who were diagnosed under age 60
No current gastrointestinal (GI) or rectal symptoms (such as rectal bleeding)
Disqualifiers
None
Trial design
Design model
Single group
Treatments tested in this trial
Educational Intervention
Other interventionUndergo education for colorectal cancer screening
Fecal Immunochemical Test
Other interventionUndergo FIT testing
Patient Navigation
BehavioralUndergo patient navigation for positive FIT results
Questionnaire Administration
Other interventionComplete questionnaire about colorectal cancer screening and healthcare
Treatment groups
450 Participants
are divided into 1 treatment groupGroup A: Screening (FIT, education, questionnaire, patient navigation)Experimental treatment 4 interventions
Trial outcomes
Primary outcomes
1
Colorectal cancer disparities seen in people of color and minority populations
Evaluate patient navigation to address colorectal cancer disparities seen in people of color, minority populations, and establish an ongoing colorectal cancer screening outreach program.
Time frame
Up to study completion, up to 30 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov